Rucci Carolyn M.
SEC insider (Form 3/4/5 filer). CIK 0002107264. SVP, Chief Legal Officer at Akebia Therapeutics, Inc. (AKBA). 4 reported Form 4/5 transactions since Sep 2024; latest on Feb 2, 2026. Located in CAMBRIDGE, MA.
Companies Rucci Carolyn M. has filed insider reports for
- Akebia Therapeutics, Inc. (AKBA): Officer, SVP, Chief Legal Officer
Rucci Carolyn M.
CIK: 0002107264
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)3 (75.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (25.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKBA
Akebia Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect16.8K shares at avg. $1.39$23K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect25.4K shares at avg. $1.39$35K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
SaleDirect27.5K shares at avg. $1.39$38K - Jan 30, 2026AKBA
Akebia Therapeutics, Inc.
AwardDirect190K shares-
1-4 of 4 transactions